ABSTRACT. We performed intracardiac electrophysioactivity, either in the surface ECG or in the His or right logic studies of the effects of vasoactive intestinal peptide ventricular electrode catheter (VIP, 0.125 pg/kg/min) on sinus and atrioventricular (AV) nodal function, intracardiac conduction, and myocardial refractoriness in two groups of neonatal dogs (aged 6-16 d). Group in autonomic physiology, f 4% (mean f SD), after exposure to 0.1-0.5 nmol of VIP ( p < 0.001). In nine other newborns (aged 4-16 days), the VIP is one o f these neuropeptides that has been identified effect of selective a,-and a2-adrenergic receptor blockade throughout the autonomic nervous system. It is a 28-amino acid on the positive c~ronotrop~c effect of VIP was evaluated. peptide that. within the heart, appears to be most highly localized ~h~ effect of VIP on sinus cycle length was not altered by in the regions o f the sinus and AV nodes and atrial myocardium. the a,-adrenergic receptor blocker prazosin or by the ,,-It is believed that VIP is most likely colocalized with acetylchoadrenergic receptor blocker yohimbine. These data indicate line within cardiac postganglionic parasympathetic nerves ( 1 ). It that, in the neonatal dog, VIP shortens sinus cycle length has been suggested that VIP may be ~hysiologically active as a and AV nodal conduction time but has no effect on infra-neurotransmitter because it has been shown to increase intrinsic nodal conduction or myocardial refractoriness. We find no cardiac pacemaker rate. enhance AV nodal conduction, and evidence that VIP's chronotropic effect is modified by a-shorten myocardial refractoriness it1 lvil8o and it1 vitro in adult adrenergic receptor blockade. V I P may play a role in the dogs (1-5) . Although the effects o f VIP in the adult heart have neural modulation of heart rate and AV nodal conduction been well described. there has been little or no information in the neonate. (Pediatr Res 35: 244-249, 1994) regarding the actions o f VIP in the developing heart. At least one study reported that the effect o f VIP on heart rate may be very Abbreviations different in the early neonatal period compared with later in life VIP, vasoactive intestinal peptide (6). This study also suggested that there might be a link between AV, atrioventricular the cardiovascular effects o f VIP and tu-adrenergic receptor activ-AH interval, the time from the onset of the atrial elecwo-ity in the newborn (6). This is o f significance because developgram to the onset of the His bundle electrogram in the mentally determined differences in cardiac chronotropic reHis electrode catheter sponses and in intracellular signal transduction in response to tu-PA interval, the time from the onset of the P wave on the adrenergic stimulation have been previously well documented surface ECG to the onset of the atrial electrogram in the (7-10). Therefore. the purpose o f our study was to characterize His electrode catheter the effects o f VIP on the electrophysiologic properties o f the H V interval, the time from the onset of the His deflection neonatal canine heart. In addition to assessing the effect o f VIP in the His electrode catheter to the onset of ventricular on sinus cycle length (in r;llo and in isolated newborn canine
ABSTRACT. We performed intracardiac electrophysioactivity, either in the surface ECG or in the His or right logic studies of the effects of vasoactive intestinal peptide ventricular electrode catheter (VIP, 0.125 pg/kg/min) on sinus and atrioventricular (AV) nodal function, intracardiac conduction, and myocardial refractoriness in two groups of neonatal dogs (aged 6-16 d) . Group I consisted of eight neonates in whom VIP was administered after bilateral vagotomy and &blockade with
Classic concepts regarding autonomic nervous system modupropranolol. Group I1 consisted of five neonates studied lation o f cardiovascular function have recently been revised since after vagotomy and propranolol, plus total chemical sym-the discovery o f a host o f neuropeptides that are colocalized with pathectomy (6-hydroxydopamine). In both groups, VIP norepinephrine in sympathetic nerves and/or acetylcholine in resulted in a significant shortening of sinus cycle length. parasympathetic nerves ( I ) . Although the physiologic signifi- in autonomic physiology, f 4% (mean f SD), after exposure to 0.1-0.5 nmol of VIP ( p < 0.001). In nine other newborns (aged 4-16 days), the VIP is one o f these neuropeptides that has been identified effect of selective a,-and a2-adrenergic receptor blockade throughout the autonomic nervous system. It is a 28-amino acid on the positive c~ronotrop~c effect of VIP was evaluated. peptide that. within the heart, appears to be most highly localized ~h~ effect of VIP on sinus cycle length was not altered by in the regions o f the sinus and AV nodes and atrial myocardium. the a,-adrenergic receptor blocker prazosin or by the ,,-It is believed that VIP is most likely colocalized with acetylchoadrenergic receptor blocker yohimbine. These data indicate line within cardiac postganglionic parasympathetic nerves ( 1 ). It that, in the neonatal dog, VIP shortens sinus cycle length has been suggested that VIP may be ~hysiologically active as a and AV nodal conduction time but has no effect on infra-neurotransmitter because it has been shown to increase intrinsic nodal conduction or myocardial refractoriness. We find no cardiac pacemaker rate. enhance AV nodal conduction, and evidence that VIP's chronotropic effect is modified by a-shorten myocardial refractoriness it1 lvil8o and it1 vitro in adult adrenergic receptor blockade. V I P may play a role in the dogs (1-5). Although the effects o f VIP in the adult heart have neural modulation of heart rate and AV nodal conduction been well described (19 + 3%) . ~h~ percent change in blood pressure was also eliminate sympathetic nerve activity as a possible cause of the determined. ~h~ infusion was then stopped and 30 min electrophysiologic effects of VIP. The efficacy of chemical SYm-were allowed for the enzymatic degradation of VIP. In four of ~athectomy in these neonates was assessed a lack the neonates, yohimbine (Sigma Chemical Co., St. Louis. MO). of change in sinus cycle length in response to a test dose of an nz-adrenerpjc receptor blocker, was administered ( 1 mg/kg tyramine as previously described ( 1 1).
AV nodal conduction time, measured a s the AH interval cance o f these neuropeptides is far from understood. it is believed
i.v.) and the VIP infusion was restarted. After the percent changes On the day of the electro~hysiology study. all neonates were in sinus cycle length and blood pressure were measured. the VIP anesthetized with sodium pentobarbital (30 mg/kg intraperito-infusion was again discontinued. In all nine neonates. the effect neally), intubated, and mechanically ventilated (Hanard model of VIP on sinus cycle length and blood pressure was determined 6 13, South ~a t i c k , MA). Arterial blood gases and blood Pressure before and after administration of the nl-adrenergic receptor were monitored through a cannula placed in the left femoral blocker prazosin ( 1 mg/kg i.v., Sigma Chemical Co, St. Louis. artery. A double lumen cannula was placed in the left femoral MO). n,-~drenergic receptor blockade was verified in these vein for the administration of drugs and infusion of VIP. Via the experiments by demonstrating near total of the right femoral vein. a 4 French quadipolar electrical catheter ( 1 -elevation in blood pressure in response to a 20-pg/kg test dose mm interelectrode spacing) was positioned in the high right of phenylephrine HCI (Elkins-Sinn Inc., C h e w Hill. NJ). The atrium for pacing the atrium and recording local atrial electro-percent increases in systolic and diastolic blood pressure before gram activity. Through the right Jugular vein, a second quadri-prazosin were 49% and 70%; after prazosin the increases were polar electrical catheter was placed in the apex of the right 3% and 3%. ventricle for the PuTose of pacing the ventricle and recording
In vitro e.\perirnent.s. Because the effects of VIP on sinus cycle ventricular electrograms. A third electrical catheter was inserted length and AV nodal conduction were similar to what would be into the left carotid artery and positioned within the noncoronary expected from catecholamine stimulation (see Results), the folcusp of the aorta for recording the low right atrium and His lowing in virro experiments were performed to demonstrate that bundle electrograms. ,411 electrograms were filtered at 30-1000 the effects of VIP were direct and not secondary to sympathetic Hz, amplified, and displayed along with surface ECG lead 11 and nerve activation (nerve endings possibly not destroyed by 6-blood Pressure using a Gould TA-2000 thermal array chart hydroxydopamine) or effects of circulating catecholamines derecorder (Could Inc.. Cleveland. OH). Paper speeds of 100-200 rived from other chromafin tissue: Hearts from five neonatal mm/s were used for measuring intracardiac conduction intervals dogs (aged 4-18 d) were rapidly excised through a midline and myocardial refractory periods. In all neonates. both vago-sternotomy after anesthesia with pentobarbital. The hearts were sympathetic trunks were severed and propranolol HCI 1 mg/kg mounted on a modified Langendorff apparatus ( 12) and under-(SoloPak Laboratories, Franklin Park. IL) was administered i.v. went retrograde aortic perfusion at constant coronary flow with In our model, this dose of propranolol completely blocks the a solution containing 62 I .2 pmol/L (100 pU/mL) insulin. 1 18 increase in heart rate caused by 0.2 pg/kg isoproterenol. mM NaCI. 4.7 mM KCI, 2.4 mM MgS04, 1.2 mM KH2P04. 25 After allowing 20 min for stabilization, the following electro-mM NaHC03, 2.4-2.6 mM CaC12. 5.5 mM glucose. and 2% physiologic study was performed: First, resting sinus cycle length BSA. Hearts were allowed to beat spontaneously and isovolumand intracardiac conduction intervals were recorded. This con-ically against a fluid-filled balloon catheter in the left ventricle. sisted of recording the intraatrial conduction time (PA interval), After stabilization for 30 min. cycle length was recorded and AV nodal conduction time (AH interval), and the His-Purkinje then VIP, 0.1 or 0.5 nmol. was given as a bolus injection over conduction time (HV interval). Next, the right atrium was paced approximately 1 s into the aortic root. The cardiac cycle length with a programmable stimulator (Bloom model DTU-2 10. Read-was then continuously recorded until the change induced by the ing, PA) at increasingly rapid rates (cycle lengths of 300 to 160 VIP bolus had fully dissipated. ms, in 40-to 20-111s decrements) for 30 s. The AH interval was S/a/i.stical ana/jvsis. For comparing sinus cycle length and all measured at each pacing interval to characterize rate-dependent electrophysiologic measurements (conduction intervals and rechanges in AV nodal conduction time. Finally. atrial and ven-fractory periods) before and after VIP (or before and after adtricular myocardial refractory periods were determined by per-ministration of the cu-antagonists). / tests for paired observations forming atrial and ventricular extrastimulation [eight-beat basic were performed. Paired / tests and two-way analyses of variance drive train (SI) at a cycle length of 260 ms, single extrastimulus were performed to analyze the interaction between cu-adrenergic (S2) delivered at IO-ms decrements until failure to capture oc-receptor blockade and the effect of VIP on sinus cycle length and curred]. The effective refractory period was defined as the longest blood pressure. A p value < 0.05 was required to indicate S1-S2 interval that failed to result in capture of the myocardium. statistical significance. All values are expressed as the mean + The functional refractory period was defined as the shortest A l -SD. A2 interval (during atrial pacing) or the shortest V1-V2 interval (during ventricular pacing) observed in response to any S 1 -S2 coupling interval.
RESlJ LTS
The entire electrophysiologic study was performed first in the In I,'ivo &ffects of VIP (Tables 1 and 2 ). I;[fi~ct.v i?/'I'IP on sin1r.s control condition. Next VIP (Peninsula Laboratories. Belmont, quYc l e t~g~/~ and hlood prc<s.slirc,. The administration of VIP to CA) was administered through the venous cannula as a contin-both group I and group I1 neonates caused a significant decrease uous infusion at a rate of 0.125 pglkglmin. This VIP dose is in sinus cycle length (increase in heart rate) (Fig. I) . In group I. similar to doses administered in previously published in vivo the sinus cycle length changed from 342 + 28 to 265 + 38 ms.
246
PICKOFF k.1. nodal conduction were more pronounced as the rate-dependent t p < 0.001 compared with control (paired t tests).
slowing of AV nodal conduction was probed by rapid atrial $ p < 0.01 compared with control (paired t tests).
pacing (Figs. 2 and 3) . As seen in Figure 3 , the curve describing the relationship between the change in the AH interval and atrial Eflects oJ' I'IP on ulriul and vcnrric-rilur rc;/jzlc'lorj3 pcriods. Atrial effective refractory periods were unchanged by VIP in both groups. Atrial functional refractory periods were unchanged by VIP in the group I neonates and prolonged slightly ( I 0 f 5%. p < 0.05) after VIP in group 11. With respect to ventricular refractory periods. in group I both the effective and functional refractory periods decreased (6 + 4% and 5 + 5%, respectively) during the VIP infusion. These small (but statistically significant) changes were not detected in the sympathectomized neonates (group 11). in whom VIP resulted in no change in either the effective or functional refractory period of the ventricle.
Effect (fa-udrc~ncrgic rc.c.c7plor h1ocker.s on curdiuc chronorropic response lo I'IP (Tuhle 3).
The change in sinus cycle length caused by VIP was unaltered by a,-adrenergic receptor blockade with prazosin. Before prazosin, VIP infusion resulted in a 19 + 3% decrease in sinus cycle length. Prazosin alone increased the resting sinus cycle length by 4 + 1 %. After prazosin. the decrease in sinus cycle length in response to VIP was 18 2%. The interaction of the effect of prazosin administration on the VIP chronotropic response was not statistically significant ( p = 0.48). Similarly, no interaction was detected in the response of systolic and diastolic blood pressure to VIP in the presence of prazosin.
Concerning cu2-adrenergic receptor blockade. the chronotropic response to VIP was similar before and after administration of the selective cu2-adrenergic receptor blocker. yohimbine. Before yohimbine, VIP caused a 17 + 3% decrease in sinus cycle length. Yohimbine alone slowed resting sinus cycle length by 4 + 2%.
After yohimbine. VIP decreased sinus cycle length by 16 f 2%. Again. no interaction was demonstrated between the chronotropic response to VIP and yohimbine administration (17 = 0.57). Changes in blood pressure in response to VIP also were unaffected by pretreatment with yohimbine. Thus, in these experiments neither t u l -or tu2-adrenergic receptor blockade modified the response of heart rate (sinus cycle length) or blood pressure to VIP.
l?(j>c.r 1!/' 17P on .41trotnuric~irj3 in I.volrltc~1 Ilc,rtrr.\. To further exclude circulating catecholamines or residual intact sympathetic nerve terminals (in group 11) as mediators of the increased automaticity observed in viro in response to VIP infusion. we studied the effects of VIP on pacemaker automaticity in isolated. 
DISCUSSION
Vasoactive intestinal peptide has been identified histochemically within the mammalian heart. It is found within cardiac nerves in high concentrations in the sinus and AV nodes and to a lesser extent within the atrial and ventricular myocardium. VIP-containing cell bodies are also demonstrable and are localized in a distribution that is similar to the distribution of vagal postganglionic cells ( 1. 2. 13-15). That VIP may be active in viva in the neuromodulation of cardiac electrophysiology was suggested by Rigel ( 16) . who demonstrated that VIP administration into the sinus node artery of anesthetized dogs resulted in a significant positive chronotropic effect. This finding complimented earlier in vilro studies in which a positive cardiac chronotropic effect of VIP was observed in a variety of experimental models (17. 18). Since then, VIP has been shown to not only increase cardiac pacemaker automaticity but to also shorten AV nodal conduction time as well as atrial and ventricular refractory periods (2) (3) (4) (5) . The cellular mechanism of VIP's effect on the heart appears to be mediated via a VIP receptor-triggered increase in adenylate cyclase activity (18). VIP is believed to be released during vagal nerve stimulation and has been implicated as the agent responsible for a significant portion of the acceleration of heart rate noted during vagal stimulation in the presence of atropine ( 19. 20) . Therefore, a growing body of evidence. both morphologic and physiologic. indicates that VIP is important in modulating cardiac electrophysiologic characteristics by the autonomic nervous system.
In the present study. we have demonstrated that exogenously administered VIP is also biologically active in the canine neonate. In the neonate. VIP significantly decreased resting sinus cycle length. as well as AV nodal conduction time. Our findings regarding the effect of VIP on sinus cycle length and on AV nodal conduction are similar to those reported by Rigel and Lathrop ( 2 ) . who studied the cardiac effects of VIP in conscious and anesthetized adult dogs. A very slight shortening of ventricular refractory periods, as reported in the adult (2) . was also noted in response to VIP, but only in the sympathetically intact (group I) neonates. Unlike the study in adult dogs. however. we did not observe a shortening of atrial refractoriness after VIP (the atrial functional refractory period actually increased slightly in the sympathectomized neonates). It is not clear why we did not observe the decrease in atrial refractoriness that would have been predicted from the data in the adult dog (2) . We did find. however, that the intraatrial conduction time (the PA interval) shortened significantly after VIP (37 + 21%. groups I and I1 combined). It is possible, therefore, that the lack of change in atrial refractoriness after VIP may, in fact, reflect some developmental difference in the ionic mechanism(s) controlling repolarization in the immature atrium rather than a lack of VIP receptors in the neonatal atrium. This could explain why intraatrial conduction was shortened by VIP, but atrial refractoriness was not. Assuming that VIP is present and colocalized with acetylcholine within parasympathetic nerves in the neonatal heart, one would expect atrial VIP receptors to be present in addition to cholinergic receptors. There is ample evidence of intact parasympathetic innervation to the newborn canine atrium (2 1). Detailed immunohistochemical studies of the distribution of VIP and VIP receptors within the developing heart would be needed to help clarify these issues.
Our findings of the effects of VIP in the neonatal canine heart differ from those reported by Mas rt al. (6) . In that study, VIP was reported to cause no increase in heart rate in young dogs (aged 5-1 8 d). In fact, heart rate actually decreased after VIP was administered. In a slightly older age group (aged 20-32 d), VIP did increase heart rate, but by only 7%. AV conduction and myocardial refractoriness were not evaluated in this study. In contrast, we did observe a significant decrease in sinus cycle length (increase in heart rate) in young neonates with a VIP infusion. We believe that this decrease in sinus cycle length was, in fact, a direct effect of VIP rather than attributable to a secondary effect of sympathetically derived or circulating catecholamines or other neurohumoral substance(s). The decrease in sinus cycle length noted in our study was not only observed in vagotomized, propranolol-treated neonates (group I), but was also observed in chemically sympathectomized neonates (group 11). We did observe, however, that the percent change in sinus cycle length was somewhat greater in the sympathetically intact neonates compared with the sympathectomized neonates (23 versus 14%). It is possible that in group I (sympathetic nerves intact) VIP, in addition to a direct effect on sinus cycle length. may also have resulted in some degree of activation of efferent sympathetic neurons, as has been reported in the adult dog (22) . Finally, as further evidence of a direct cardiac effect of VIP. a positive chronotropic effect of VIP was also demonstrated in vitro in isolated hearts of similar age. Thus, we believe that VIP does. in fact, increase pacemaker automaticity in the neonatal canine heart, as reported in the adult. We do not know the reasons that our findings differ from the observations of Mas d al. (6) .
In our study, we also investigated whether a-adrenergic receptor blockade altered the cardiac chronotropic response to VIP. A coupling between a-adrenergic receptor activity and the effects of VIP has been suggested in other organ system models. For example, it has previously been demonstrated that a,-receptor stimulation can significantly potentiate the increase in intracellular cAMP production caused by VIP. The increase in cAMP observed in response to simultaneous receptor activation is greater than the increase observed with either receptor type alone (23, 24) . In contrast, a?-receptor stimulation has been shown to antagonize the metabolic effects of VIP in isolated rat enterocytes (25) and to inhibit stimulation of cAMP by VIP in rabbit ciliary processes (26) .
In the cardiovascular system, Mas ct ul. (6) reported that nonselective n-adrenergic receptor blockade with phentolamine significantly potentiated the hypotensive effect of VIP in neonatal dogs. These authors suggested that there might be a complex relationship between a-adrenergic receptor activity and the cardiovascular effects of VIP in the neonate. In our study. we observed no significant difference in the positive chronotropic effect of VIP after either 0 , -or a?-adrenergic receptor blockade. In regard to blood pressure, although the decrease in systolic and diastolic blood pressure after VIP plus prazosin was slightly greater than after VIP alone (Table 3) . no statistical interaction could be shown between VIP's effect on blood pressure and prazosin administration. Changes in blood pressure in response to VIP were identical before and after yohimbine administration. Therefore, in our experiments. no clear relationship was found between tu-adrenergic receptor activity and the cardiovascular effects of VIP in the neonatal dog. A possible link between VIP and n-adrenergic activity in the neonatal dog might be further investigated using selective adrenergic agonists in addition to selective adrenergic receptor blockers. In summary. our data demonstrate that VIP is a biologically active neuropeptide in the neonatal heart. VIP significantly decreases sinus cycle length and AV nodal conduction in these hearts. In this study, no clear interaction could be demonstrated between tr-adrenergic receptor blockade and the effect of VIP on sinus cycle length and blood pressure. A relationship between these two diverse receptor subtypes, however. is not fully excluded and warrants further investigation. Given the electrophysiologic effects of VIP in the neonatal heart, it is likely that VIP plays a role in the regulation of heart rate and blood pressure by the autonomic nervous system. .-lc~knorr~l~~dgtnrnr. The authors thank Philip J. Kadowitz. Ph.D.. for his helpful insight and assistance.
